OVERVIEW: During the initial funding period, the program has made significant advances in molecular imaging through the combined creative efforts of its investigators. These advances in molecular imaging have led to the development of novel molecular imaging reporter molecules which have been used to improve our understanding of cancer etiology, biology, pathophysiology and therapy. In this renewal ICMIC application, we will continue to develop cutting edge approaches for imaging the presence of pre-malignant (dysplastic) tissue and oncogenic signaling molecules in vivo. Project 1 will develop an integrated optical molecular imaging strategy that uses fluorescence peptides as probes to target the presence of premalignant (dysplastic) tissue in vivo. This Project will develop novel optical imaging probes and instruments that can be used in pre-clinical models as well as translated to the clinic as practical screening tools for the early detection of cancer in hollow organs. Project 2 will develop and validate molecular imaging reporters (i.e. EGFR, Met and Akt). Non-invasive imaging in cells and animals will be used to evaluate these novel reporter constructs for detection of key oncogenic signaling pathways. Project 3 will develop molecular imaging tools for imaging of signaling pathways in gliomas and for imaging of the glioma stem cell subpopulation. These tools and concepts should significantly aid in our preclinical drug development process and provide insights into more efficacious combination therapy strategies for brain tumors. The proposal includes a Career Development Program which provides the opportunity to train and interact with young, enthusiastic molecular imaging investigators. The Pilot Program will enable recruitment of outstanding scientists to the molecular imaging field by providing funding, ideas and resources to facilitate ongoing research. Core A, the administrative core will provide administrative and statistical support to all projects and will also facilitate External and Internal scientific review of all projects. The imaging Core (Core B) will provide imaging expertise and equipment for all of the animal imaging needs of this ICMIC. The Biostatistics Core (Core C) will provide for all of the biostatistical analysis of all of the Projects, Pilot Projects and Career Development Awardees. One of the central goals of the UM-ICMIC program is to bridge the great divide between quality patient care and laboratory studies in cancer research. This continues to be the driving force in the current proposal.

Public Health Relevance

This effort will enhance patient care through the development of unique molecular imaging capabilities which will improve our ability to detect (image) pre-neoplastic lesions, enhance the drug development process, delineate the signaling differences in the cancer stem cell population and assist in the identification of rationale-based combination therapies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA093990-10
Application #
8120952
Study Section
Special Emphasis Panel (ZCA1-SRRB-9 (J1))
Program Officer
Menkens, Anne E
Project Start
2002-06-14
Project End
2013-08-31
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
10
Fiscal Year
2011
Total Cost
$1,553,413
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Keith, Lauren; Ross, Brian D; Galbán, Craig J et al. (2016) Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response Mapping. Tomography 2:267-275
Nyati, Shyam; Chator, Areeb; Schinske, Katerina et al. (2016) A Requirement for ZAK Kinase Activity in Canonical TGF-? Signaling. Transl Oncol 9:473-481
Stacer, A C; Fenner, J; Cavnar, S P et al. (2016) Endothelial CXCR7 regulates breast cancer metastasis. Oncogene 35:1716-24
Al-Dujaili, Saja A; Koh, Amy J; Dang, Ming et al. (2016) Calcium Sensing Receptor Function Supports Osteoblast Survival and Acts as a Co-Factor in PTH Anabolic Actions in Bone. J Cell Biochem 117:1556-67
Joshi, Bishnu P; Pant, Asha; Duan, Xiyu et al. (2016) Multimodal Video Colonoscope for Targeted Wide-Field Detection of Nonpolypoid Colorectal Neoplasia. Gastroenterology 150:1084-1086
Baer, A H; Hoff, B A; Srinivasan, A et al. (2015) Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer. AJNR Am J Neuroradiol 36:757-62
Boes, Jennifer L; Bule, Maria; Hoff, Benjamin A et al. (2015) The Impact of Sources of Variability on Parametric Response Mapping of Lung CT Scans. Tomography 1:69-77
Luker, K E; Pata, P; Shemiakina, I I et al. (2015) Comparative study reveals better far-red fluorescent protein for whole body imaging. Sci Rep 5:10332
Chang, S Laura; Cavnar, Stephen P; Takayama, Shuichi et al. (2015) Cell, isoform, and environment factors shape gradients and modulate chemotaxis. PLoS One 10:e0123450
Wang, Lizhong; Liu, Runhua; Ye, Peiying et al. (2015) Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nat Commun 6:5909

Showing the most recent 10 out of 161 publications